Delivery Order SPE2DB22D3301-SPE2DB25FY8XP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loperamide 2 mg capsules (100-count units) valued at $1,130.55 with a firm fixed price structure and completion deadline of August 15, 2025. This is a non-set-aside competitively awarded contract executed under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Loperamide 2 mg capsules in quantities of 500 units. This firm fixed-price delivery order, valued at $1,759.50, represents a non-set-aside competitive award with an ultimate completion date of August 27, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loperamide 2 mg capsules in unit dose packages of 100 units. This firm fixed-price delivery order, valued at $2,927.06, represents a non-competitive set-aside award and is scheduled for ultimate completion by July 22, 2025. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,063.67 and an ultimate completion date of September 5, 2025. The contract represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg with a ceiling value of $1,299.86 on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is not designated as a set-aside contract and was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for 500 capsules of Loperamide 2 mg with a ceiling value of $1,586.28. This firm fixed-price delivery order, which must be completed by September 23, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 500 capsules of Loperamide 2 mg at a ceiling value of $1,234.15. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is set to be completed by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,382.15 for 500 capsules of Loperamide 2 mg on September 11, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by September 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction issued under the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Loperamide Hydrochloride with a ceiling value of $2,204.30. The contract, awarded on September 19, 2025, with ultimate completion by September 22, 2025, was competitively awarded with no set-aside designation and structured as a firm fixed-price delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this requirement through its...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8XPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Loperamide 2 mg capsules (100-count units) valued at $16,158.96. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. This delivery order for loperamide, an anti-diarrheal medication, exemplifies the company's role in fulfilling essential pharmaceutical needs across the Defense Health Agency and other federal healthcare systems. The SPE2DX contract vehicle enables flexible procurement of brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/6/25 |